Veracyte, Inc.
Jens Holstein (Director) sells VCYT shares
About this filing
Veracyte, Inc. (VCYT) filed Form 4 (insider transaction) with the SEC on Oct 28, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Jens Holstein · Director
Rule 10b5-1 plan · adopted Jun 12, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +7,500 | $35.30 | $264,750.00 | 34,971 | Direct |
| Sep 24, 2026 | S · open-market saleFootnotes F1, F2 | −7,500 | $47.00 | $352,500.00 | 27,471 | Direct |
| Oct 27, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +7,500 | $35.30 | $264,750.00 | 34,971 | Direct |
| Oct 27, 2026 | S · open-market saleFootnotes F1 | −7,500 | $50.00 | $375,000.00 | 27,471 | Direct |
| Sep 24, 2026 | M · exercise or conversion of a derivativeStock Option (right to buy)Footnotes F1, F2, F3 | −7,500 | $0.00 | $0.00 | 27,500 | Direct |
| Oct 27, 2026 | M · exercise or conversion of a derivativeStock Option (right to buy)Footnotes F1, F3 | −7,500 | $0.00 | $0.00 | 20,000 | Direct |
Footnotes
- F1 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2026.
- F2 The transaction reported on this line was not timely reported due to an inadvertent administrative error not attributable to the reporting person.
- F3 The option is fully vested.
More VCYT filings
- SC 13G/A
Filed Nov 5, 2026
- 10-Q
Filed Nov 5, 2026
- 8-K
Filed Nov 4, 2026
- 4
Filed Oct 29, 2026
- 4
Filed Oct 28, 2026
- 144
Filed Oct 27, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.